INTERIUS
Live / Registered — Registered (as of 27 Aug 2024)
What this means for you
Registered since 27 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97592364
- Registration number
- 7489719
- Mark type
- Stylized text
- Filed
- 15 Sept 2022
- Published for opposition
- 01 Aug 2023
- Registered
- 27 Aug 2024
- Attorney of record
- Sean P. McConnell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for use in the treatment of cancers, blood diseases, and blood disorders
Owner
- Interius BioTherapeutics, Inc., Philadelphia, PA, US
- Interius BioTherapeutics, Inc., Philadelphia, PA, US
- Interius BioTherapeutics, Inc., Philadelphia, PA, US
Prosecution history
- 27 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 20 May 2024 — USE AMENDMENT FILED
- 26 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 21 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Oct 2023 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 30 Aug 2023 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 01 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Aug 2023 — PUBLISHED FOR OPPOSITION
- 12 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jun 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER